Tranexamic acid in traumatic brain injury: systematic review and meta-analysis trumps a large clinical trial?
Intensive Care Med
.
2021 Jan;47(1):74-76.
doi: 10.1007/s00134-020-06305-x.
Epub 2020 Oct 31.
Authors
Andrew I R Maas
1
,
Ewout W Steyerberg
2
3
,
Giuseppe Citerio
4
Affiliations
1
Department of Neurosurgery, Antwerp University Hospital and University of Antwerp, Wilrijkstraat 10, 2650, Edegem, Belgium. andrew.maas@uza.be.
2
Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
3
Center for Medical Decision Sciences, Department of Public Health, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.
4
School of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
PMID:
33128570
DOI:
10.1007/s00134-020-06305-x
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antifibrinolytic Agents* / therapeutic use
Brain Injuries* / drug therapy
Brain Injuries, Traumatic* / drug therapy
Humans
Tranexamic Acid* / therapeutic use
Substances
Antifibrinolytic Agents
Tranexamic Acid